Foghorn Therapeutics Files 2025 Proxy Statement
Ticker: FHTX · Form: DEF 14A · Filed: May 5, 2025 · CIK: 1822462
| Field | Detail |
|---|---|
| Company | Foghorn Therapeutics Inc. (FHTX) |
| Form Type | DEF 14A |
| Filed Date | May 5, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, governance
Related Tickers: FHTX
TL;DR
Foghorn (FHTX) proxy filed. Annual meeting June 17. Vote your shares!
AI Summary
Foghorn Therapeutics Inc. filed its definitive proxy statement (DEF 14A) on May 5, 2025, for its annual meeting on June 17, 2025. The company, located at 500 Technology Square, Cambridge, MA, is involved in pharmaceutical preparations. This filing outlines the agenda and proposals for the upcoming shareholder meeting.
Why It Matters
This filing provides shareholders with crucial information regarding the company's governance and voting matters for the upcoming annual meeting, impacting their ability to influence corporate decisions.
Risk Assessment
Risk Level: low — This is a routine proxy filing for an annual shareholder meeting and does not contain new material financial or operational information.
Key Numbers
- 2024-12-31 — Fiscal Year End (Indicates the period for which financial reporting is relevant.)
Key Players & Entities
- Foghorn Therapeutics Inc. (company) — Registrant
- May 5, 2025 (date) — Filing Date
- June 17, 2025 (date) — Meeting Date
- 500 Technology Square, Cambridge, MA (address) — Company Headquarters
FAQ
What is the purpose of this DEF 14A filing?
The purpose of this DEF 14A filing is to provide Foghorn Therapeutics Inc. shareholders with information regarding the company's annual meeting of stockholders, including the date, time, and location of the meeting, as well as the proposals to be voted upon.
When is Foghorn Therapeutics Inc.'s annual meeting scheduled?
Foghorn Therapeutics Inc.'s annual meeting is scheduled for June 17, 2025.
What is the filing date of this proxy statement?
This definitive proxy statement was filed with the SEC on May 5, 2025.
Where is Foghorn Therapeutics Inc. headquartered?
Foghorn Therapeutics Inc. is headquartered at 500 Technology Square, Suite 700, Cambridge, MA 02139.
What is the Standard Industrial Classification (SIC) code for Foghorn Therapeutics Inc.?
The Standard Industrial Classification (SIC) code for Foghorn Therapeutics Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on May 5, 2025 regarding Foghorn Therapeutics Inc. (FHTX).